These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 14656230)

  • 1. Bronchodilator reversibility in Australian adults with chronic obstructive pulmonary disease.
    Reid DW; Soltani A; Johns DP; Bish R; Williams TJ; Burns GP; Walters EH
    Intern Med J; 2003 Dec; 33(12):572-7. PubMed ID: 14656230
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combined Forced Expiratory Volume in 1 Second and Forced Vital Capacity Bronchodilator Response, Exacerbations, and Mortality in Chronic Obstructive Pulmonary Disease.
    Fortis S; Comellas A; Make BJ; Hersh CP; Bodduluri S; Georgopoulos D; Kim V; Criner GJ; Dransfield MT; Bhatt SP;
    Ann Am Thorac Soc; 2019 Jul; 16(7):826-835. PubMed ID: 30908927
    [No Abstract]   [Full Text] [Related]  

  • 3. Which bronchodilator reversibility criteria can predict severe acute exacerbation in chronic obstructive pulmonary disease patients?
    Kim J; Kim WJ; Lee CH; Lee SH; Lee MG; Shin KC; Yoo KH; Lee JH; Lim SY; Na JO; Hwang HG; Hong Y; Lim MN; Yoo CG; Jung KS; Lee SD
    Respir Res; 2017 May; 18(1):107. PubMed ID: 28558829
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A New Bronchodilator Response Grading Strategy Identifies Distinct Patient Populations.
    Hansen JE; Dilektasli AG; Porszasz J; Stringer WW; Pak Y; Rossiter HB; Casaburi R
    Ann Am Thorac Soc; 2019 Dec; 16(12):1504-1517. PubMed ID: 31404502
    [No Abstract]   [Full Text] [Related]  

  • 5. Bronchodilator Response in FVC Is Larger and More Relevant Than in FEV
    Quanjer PH; Ruppel GL; Langhammer A; Krishna A; Mertens F; Johannessen A; Menezes AMB; Wehrmeister FC; Perez-Padilla R; Swanney MP; Tan WC; Bourbeau J
    Chest; 2017 May; 151(5):1088-1098. PubMed ID: 28040521
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bronchodilator Responsiveness Defined by the 2005 and 2021 ERS/ATS Criteria in Patients with Asthma as Well as Chronic Obstructive Pulmonary Disease.
    Li Y; Lin J; Wang Z; Wang Z; Tan L; Liu S; Huang J; Gao Y; Zheng J
    Int J Chron Obstruct Pulmon Dis; 2022; 17():2623-2633. PubMed ID: 36274994
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differences in clinical significance of bronchodilator responses measured by forced expiratory volume in 1 second and forced vital capacity.
    Choi JY; Kim SK; Lee JH; Jung KS; Yoo KH; Hwang KE; Lee JD; Kim YI; Yoon HK; Um SJ
    PLoS One; 2023; 18(2):e0282256. PubMed ID: 36827406
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combination therapy of inhaled steroids and long-acting beta2-agonists in asthma-COPD overlap syndrome.
    Lee SY; Park HY; Kim EK; Lim SY; Rhee CK; Hwang YI; Oh YM; Lee SD; Park YB
    Int J Chron Obstruct Pulmon Dis; 2016; 11():2797-2803. PubMed ID: 27877033
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characteristics of reversible and nonreversible COPD and asthma and COPD overlap syndrome patients: an analysis of salbutamol Easyhaler data.
    Müller V; Gálffy G; Orosz M; Kováts Z; Odler B; Selroos O; Tamási L
    Int J Chron Obstruct Pulmon Dis; 2016; 11():93-101. PubMed ID: 26834466
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Measures of bronchodilator response of FEV
    Torén K; Bake B; Olin AC; Engström G; Blomberg A; Vikgren J; Hedner J; Brandberg J; Persson HL; Sköld CM; Rosengren A; Bergström G; Janson C
    Int J Chron Obstruct Pulmon Dis; 2017; 12():973-980. PubMed ID: 28356729
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bronchodilator Responsiveness in Tobacco-Exposed People With or Without COPD.
    Fortis S; Quibrera PM; Comellas AP; Bhatt SP; Tashkin DP; Hoffman EA; Criner GJ; Han MK; Barr RG; Arjomandi M; Dransfield MB; Peters SP; Dolezal BA; Kim V; Putcha N; Rennard SI; Paine R; Kanner RE; Curtis JL; Bowler RP; Martinez FJ; Hansel NN; Krishnan JA; Woodruff PG; Barjaktarevic IZ; Couper D; Anderson WH; Cooper CB;
    Chest; 2023 Mar; 163(3):502-514. PubMed ID: 36395858
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Substantial variation exists in spirometry interpretation practices for airflow obstruction in accredited lung function laboratories across Australia and New Zealand.
    Holt NR; Thompson BR; Miller B; Borg BM
    Intern Med J; 2019 Jan; 49(1):41-47. PubMed ID: 30043534
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bronchodilator reversibility in asthma and COPD: findings from three large population studies.
    Janson C; Malinovschi A; Amaral AFS; Accordini S; Bousquet J; Buist AS; Canonica GW; Dahlén B; Garcia-Aymerich J; Gnatiuc L; Kowalski ML; Patel J; Tan W; Torén K; Zuberbier T; Burney P; Jarvis D
    Eur Respir J; 2019 Sep; 54(3):. PubMed ID: 31221806
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diagnostic value of post-bronchodilator pulmonary function testing to distinguish between stable, moderate to severe COPD and asthma.
    Richter DC; Joubert JR; Nell H; Schuurmans MM; Irusen EM
    Int J Chron Obstruct Pulmon Dis; 2008; 3(4):693-9. PubMed ID: 19281083
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of forced inspiratory vital capacity to identify bronchodilator reversibility in obstructive lung disease.
    Biring MS; Madison S; Mohsenifar Z
    J Asthma; 2001 Sep; 38(6):495-500. PubMed ID: 11642416
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The objective evaluation of obstructive pulmonary diseases with spirometry.
    Ozkaya S; Dirican A; Tuna T
    Int J Chron Obstruct Pulmon Dis; 2016; 11():2009-15. PubMed ID: 27616884
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Improved criterion for assessing lung function reversibility.
    Ward H; Cooper BG; Miller MR
    Chest; 2015 Oct; 148(4):877-886. PubMed ID: 25879725
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Study of the clinical phenotype of symptomatic chronic airways disease by hierarchical cluster analysis and two-step cluster analyses].
    Ning P; Guo YF; Sun TY; Zhang HS; Chai D; Li XM
    Zhonghua Nei Ke Za Zhi; 2016 Sep; 55(9):679-83. PubMed ID: 27586974
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Determinants of initial inhaled corticosteroid use in patients with GOLD A/B COPD: a retrospective study of UK general practice.
    Chalmers JD; Tebboth A; Gayle A; Ternouth A; Ramscar N
    NPJ Prim Care Respir Med; 2017 Jun; 27(1):43. PubMed ID: 28663549
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Asthma-COPD overlap syndrome (ACOS) in primary care of four Latin America countries: the PUMA study.
    Montes de Oca M; Victorina Lopez Varela M; Laucho-Contreras ME; Casas A; Schiavi E; Mora JC
    BMC Pulm Med; 2017 Apr; 17(1):69. PubMed ID: 28431499
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.